The Southern Philippines Medical Center (SPMC) has achieved a significant milestone in digital healthcare by becoming the first government hospital in the Southern Philippines to adopt UpToDate® Expert AI. The move will provide SPMC’s healthcare professionals with a sophisticated clinical decision support tool designed to ground generative AI in verifiable medical evidence.
The adoption comes at a critical time. While general-purpose generative AI has made health information instantly accessible, it often lacks transparency. For medical professionals, a convincing AI-generated answer is not enough; they must know where the information comes from, what evidence supports it, and whether that evidence can be independently examined.
Bringing Transparency to Clinical AI
Unlike general-purpose AI tools, UpToDate® Expert AI is built specifically for clinical environments. It merges generative AI with UpToDate’s extensive, expert-authored, and peer-reviewed clinical content.
When clinicians ask questions in natural language, the AI provides responses directly grounded in this verified content, complete with supporting sources that can be reviewed. The distinction lies not just in the answers generated, but in making the evidence behind those answers visible, transparent, and verifiable. Furthermore, clinical experts are continuously involved in the development and review of the tool.
By adopting this technology, SPMC provides a real-world model for how public healthcare institutions in the Philippines can navigate the emerging AI landscape, focusing on evidence provenance, transparency, and clinical oversight.
AI as a Support, Not a Replacement
The integration of AI in healthcare raises important questions about governance and professional judgment. UpToDate Expert AI is designed to support clinical reasoning rather than replace it. With transparent sourcing, the healthcare professional remains entirely responsible for interpreting information in context and applying their expertise.
“Trust is the foundation of clinical AI,” said Dr. Sheila Bond, Head of Clinical Artificial Intelligence at Wolters Kluwer Health. “It is not simply about generating an answer; it is about making the evidence behind that answer visible, reviewable, and grounded in human expertise. Responsible AI integration requires a focus on transparency, governance, and ensuring clinicians remain in control.”
An Evolving Landscape in APAC and Beyond
SPMC’s adoption of this technology aligns with a growing global trend of healthcare systems exploring responsible AI integration.
Hong Nguyen, Regional Sales Director, APAC at Wolters Kluwer Health, notes that hospital leaders across the region are increasingly focused on trust. “As approaches to clinical AI evolve, transparency and evidence are becoming non-negotiable factors in adoption,” Nguyen said. “SPMC’s proactive step sets a strong precedent for public healthcare institutions in the region.”
Globally, this reflects a broader digital transformation across health ministries and systems. Christian Cella, Vice President and General Manager, International at Wolters Kluwer Health, emphasizes that as healthcare becomes increasingly digital, the reliance on trusted clinical information is paramount. “Health systems internationally are approaching AI with a focus on responsible adoption,” Cella stated. “Ensuring that technology is built on a foundation of trusted, expert-backed clinical information is essential for improving outcomes and maintaining clinician confidence.”
About Wolters Kluwer
Wolters Kluwer (EURONEXT: WKL) is a global leader in information solutions, software and services for professionals in healthcare; tax and accounting; financial and corporate compliance; legal and regulatory; corporate performance and ESG. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with technology and services.
Wolters Kluwer reported 2025 annual revenues of €6.1 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 21,100 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX, Euro Stoxx 50, and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information, visit www.wolterskluwer.com.


